4-METHYL-N-[3-4-METHYLIMIDAZOL-1-YL)-5-TRIFLUOROMETHYLPHENYL]-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)BENZAMIDE SALTS Russian patent published in 2014 - IPC C07D401/14 A61P35/00 

Abstract RU 2509767 C1

FIELD: chemistry.

SUBSTANCE: invention relates to a novel sulphate of 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)benzamide, which can be used in treating diseases which respond to protein kinase inhibition. The sulphate is obtained by reacting 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)benzamide in form of a free base with sulphuric acid in a solvent medium.

EFFECT: salt has low hygroscopicity and high solubility.

2 cl, 8 dwg, 17 tbl, 11 ex

Similar patents RU2509767C1

Title Year Author Number
SALTS OF 4-METHYL-N-[3-(4-METHYLIMIDAZOLE-1-YL)-5-TRIFLUOROMETHYLPHENYL]-3-(4-PYRIDINE-3-YLPYRIMIDINE-2-YLAMINO)BENZAMIDE 2013
  • Manli Pol U.
  • Shi Venchun
  • Satton Pol Allen
  • Karpinski Peter Kh.
  • Vu Rain
  • Monne Stefani
  • Brotsio Jerg
RU2605551C2
4-METHYL-N-[3-(4-METHYLIMIDAZOL-1-YL)-5-TRIFLUOROMETHYLPHENYL]-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)BENZAMIDE SALTS 2006
  • Manli Pol U.
  • Shi Vehn'Chun
  • Satton Pol Allen
  • Karpinski Petr Kh.
  • Vu Rain
  • Monn'E Stefani
  • Brotsio Jerg
RU2483065C2
4-METHYL-[3-(4-METHYLIMIDAZOL-1-YL)-5-TRIFLUOROMETHYLPHENYL]-3-(4-PYRIDIN-3-YLPYRIMIDIN-2-YLAMINO)BENZAMIDE SALTS 2006
  • Manli Pol U.
  • Shi Vehn'Chun
  • Satton Pol Allen
  • Karpinski Petr Kh.
  • Vu Rain
  • Monn'E Stefani
  • Brotsio Jerg
RU2434864C2
NOVEL CRYSTALLINE SALT FORM 3-(1,2,4-TRIAZOLO[4,3-A]PYRIDIN-3-YLETHYNYL)-4-METHYL-N-(4-((4-METHYLPIPERAZIN-1-YL)METHYL)-3-TRIFLUOROMETHYLPHENYL) BENZAMIDE FOR MEDICAL APPLICATION 2016
  • Chilov Germes Grigorevich
  • Titov Ilya Yurevich
RU2652992C2
NOVEL CRYSTALLINE FORMS OF SODIUM SALT OF (4-{4-[5-(6-TRIFLUOROMETHYL-PYRIDIN-3-YLAMINO)PYRIDIN-2-YL]PHENYL}CYCLOHEXYL) ACETIC ACID 2011
RU2612556C2
NANOSIZE WEAKLY CRYSTALLINE MODIFICATION OF 4-METHYL-N-[3-(4-METHYLIMIDAZOL-1-YL)-5-(TRIFLUOROMETHYL)PHENYL]-3-[(4-PYRIDIN-3-YLPYRIMIDIN-2-YL)AMINO]BENAZAMIDE HYDROCHLORIDE MONOHYDRATE, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION BASED THEREON 2013
  • Malin Aleksandr Aleksandrovich
  • Mikhajlov Oleg Rostislavovich
  • Uvarov Nikolaj Aleksandrovich
RU2551359C1
METHOD OF PRODUCING N-[5-(3,5-DIFTORBENZIL)-1H-INDAZOLE-3-YL]-4-(4-METHYLPIPERAZINE-1-YL)-2-(TETRAHYDROPYRAN-4-YLAMINO)BENZAMIDE 2013
  • Barbudzhan Natale Alvaro
  • Forino Romualdo
  • Orsini Paolo
RU2602071C2
POLYMORPHIC MODIFICATIONS OF N-[(3-FLUORO-4-METHOXYPYRIDINE-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({ 4-[(2-OXOPYRIDINE-1-YL)METHYL]PHENYL} METHYL)PYRAZOLE-4-CARBOXAMIDE AND THEIR SALTS 2017
  • Beaton, Haydn
  • Crowe, David Malcolm
  • Edwards, Hannah Joy
  • Griffiths-Haynes, Nicholas James
RU2756273C2
NEW CRYSTALLINE MODIFICATION 2-(3, 5-BIS-TRIFLUOROMETHYLPHENYL)-H-[6-(1, 1-DIOXO-1 λ -THIOMORPHOLINE-4-YL)-4-(4-FLUORO-2-MEHTYLPHENYL)PIRIDINE-3-YL]-K-METHYLISOBUTYR AMIDE 2004
  • Khoffmann Torsten
  • Khoffmann-Ehmeri Fabinne
  • Nikk Sonja
  • Shvitter Urs
  • Val'Dmajer Pius
RU2330022C2
COMPOUNDS AND COMPOSITIONS AS PROTEIN TYROSINE KINASE INHIBITORS 2006
  • Chzhan Guobao
  • Rehn' Pinda
  • Van Sja
  • Grej Natanael Sh.
  • Sim Taehbo
RU2386630C2

RU 2 509 767 C1

Authors

Manli Pol U.

Shi Vehn'Chun

Satton Pol Allen

Karpinski Petr Kh.

Vu Rain

Monn'E Stefani

Brotsio Jerg

Dates

2014-03-20Published

2006-07-18Filed